Suppr超能文献

Kibra 作为一种肿瘤抑制蛋白,与 Merlin 和 Expanded 一起调节 Hippo 信号通路。

Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded.

机构信息

Department of Biological Science, Florida State University, Tallahassee, FL 32306, USA.

出版信息

Dev Cell. 2010 Feb 16;18(2):288-99. doi: 10.1016/j.devcel.2009.12.012.

Abstract

The Hippo signaling pathway regulates organ size and tissue homeostasis from Drosophila to mammals. Central to this pathway is a kinase cascade wherein Hippo (Hpo), in complex with Salvador (Sav), phosphorylates and activates Warts (Wts), which in turn phosphorylates and inactivates the Yorkie (Yki) oncoprotein, known as the YAP coactivator in mammalian cells. The FERM domain proteins Merlin (Mer) and Expanded (Ex) are upstream components that regulate Hpo activity through unknown mechanisms. Here we identify Kibra as another upstream component of the Hippo signaling pathway. We show that Kibra functions together with Mer and Ex in a protein complex localized to the apical domain of epithelial cells, and that this protein complex regulates the Hippo kinase cascade via direct binding to Hpo and Sav. These results shed light on the mechanism of Ex and Mer function and implicate Kibra as a potential tumor suppressor with relevance to neurofibromatosis.

摘要

Hippo 信号通路从果蝇到哺乳动物,调节器官大小和组织平衡。该通路的核心是一个激酶级联反应,其中 Hippo(Hpo)与 Salvador(Sav)复合物磷酸化并激活 Warts(Wts),而 Wts 又磷酸化并失活 Yorkie(Yki)癌蛋白,在哺乳动物细胞中称为 YAP 共激活因子。FERM 结构域蛋白 Merlin(Mer)和 Expanded(Ex)是上游组件,通过未知机制调节 Hpo 活性。在这里,我们将 Kibra 鉴定为 Hippo 信号通路的另一个上游组件。我们表明,Kibra 与 Mer 和 Ex 一起在一个蛋白复合物中发挥作用,该复合物定位于上皮细胞的顶端域,并且该蛋白复合物通过直接与 Hpo 和 Sav 结合来调节 Hippo 激酶级联反应。这些结果阐明了 Ex 和 Mer 功能的机制,并暗示 Kibra 是一种潜在的肿瘤抑制因子,与神经纤维瘤病有关。

相似文献

2
Kibra is a regulator of the Salvador/Warts/Hippo signaling network.
Dev Cell. 2010 Feb 16;18(2):300-8. doi: 10.1016/j.devcel.2009.12.011.
3
The WW domain protein Kibra acts upstream of Hippo in Drosophila.
Dev Cell. 2010 Feb 16;18(2):309-16. doi: 10.1016/j.devcel.2009.12.013.
4
The Hippo tumor-suppressor pathway regulates apical-domain size in parallel to tissue growth.
J Cell Sci. 2009 Jul 15;122(Pt 14):2351-9. doi: 10.1242/jcs.046482. Epub 2009 Jun 16.
5
The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded.
Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10532-7. doi: 10.1073/pnas.1004279107. Epub 2010 May 24.
6
Ajuba LIM proteins are negative regulators of the Hippo signaling pathway.
Curr Biol. 2010 Apr 13;20(7):657-62. doi: 10.1016/j.cub.2010.02.035. Epub 2010 Mar 18.
7
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control.
Dev Cell. 2008 Mar;14(3):377-87. doi: 10.1016/j.devcel.2008.01.006. Epub 2008 Feb 7.
8
The Hippo pathway and apico-basal cell polarity.
Biochem J. 2011 Jun 1;436(2):213-24. doi: 10.1042/BJ20110217.
9
The cell adhesion molecule echinoid functions as a tumor suppressor and upstream regulator of the Hippo signaling pathway.
Dev Cell. 2012 Feb 14;22(2):255-67. doi: 10.1016/j.devcel.2011.12.011. Epub 2012 Jan 25.
10
The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway.
Dev Cell. 2008 Mar;14(3):388-98. doi: 10.1016/j.devcel.2008.01.007. Epub 2008 Feb 7.

引用本文的文献

2
Targeting the Hippo pathway in cancer.
Nat Rev Drug Discov. 2025 Jun 30. doi: 10.1038/s41573-025-01234-0.
4
The N-terminus of the effector Tarp engages the host Hippo pathway.
Microbiol Spectr. 2025 Apr;13(4):e0259624. doi: 10.1128/spectrum.02596-24. Epub 2025 Mar 10.
7
WWC proteins-mediated compensatory mechanism restricts schwannomatosis driven by loss of function.
Sci Adv. 2025 Jan 24;11(4):eadp4765. doi: 10.1126/sciadv.adp4765. Epub 2025 Jan 22.
8
Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.
Signal Transduct Target Ther. 2025 Jan 6;10(1):4. doi: 10.1038/s41392-024-02070-1.
9
Dietary Palmitic Acid Drives a Palmitoyltransferase ZDHHC15-YAP Feedback Loop Promoting Tumor Metastasis.
Adv Sci (Weinh). 2025 Feb;12(6):e2409883. doi: 10.1002/advs.202409883. Epub 2024 Dec 16.

本文引用的文献

3
Boundaries of Dachsous Cadherin activity modulate the Hippo signaling pathway to induce cell proliferation.
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14897-902. doi: 10.1073/pnas.0805201105. Epub 2008 Sep 22.
4
Morphogen control of wing growth through the Fat signaling pathway.
Dev Cell. 2008 Aug;15(2):309-21. doi: 10.1016/j.devcel.2008.06.003.
5
KIBRA modulates directional migration of podocytes.
J Am Soc Nephrol. 2008 Oct;19(10):1891-903. doi: 10.1681/ASN.2007080916. Epub 2008 Jul 2.
7
MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation.
Curr Biol. 2008 Mar 11;18(5):311-21. doi: 10.1016/j.cub.2008.02.006.
8
SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila.
Curr Biol. 2008 Mar 25;18(6):435-41. doi: 10.1016/j.cub.2008.02.034. Epub 2008 Feb 28.
9
The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway.
Dev Cell. 2008 Mar;14(3):388-98. doi: 10.1016/j.devcel.2008.01.007. Epub 2008 Feb 7.
10
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control.
Dev Cell. 2008 Mar;14(3):377-87. doi: 10.1016/j.devcel.2008.01.006. Epub 2008 Feb 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验